TY - JOUR
T1 - Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis
T2 - a systematic review of early outcomes with pooled analysis
AU - Spadaccini, Marco
AU - Maselli, Roberta
AU - Chandrasekar, Viveksandeep Thoguluva
AU - Anderloni, Andrea
AU - Carrara, Silvia
AU - Galtieri, Piera Alessia
AU - Di Leo, Milena
AU - Fugazza, Alessandro
AU - Pellegatta, Gaia
AU - Colombo, Matteo
AU - Palma, Rossella
AU - Hassan, Cesare
AU - Sethi, Amrita
AU - Khashab, Mouen A.
AU - Sharma, Prateek
AU - Repici, Alessandro
N1 - Publisher Copyright:
© 2020 American Society for Gastrointestinal Endoscopy
PY - 2020/4
Y1 - 2020/4
N2 - Background and Aims: Gastroparesis (GP) is a chronic debilitating condition. Prior pyloric-targeted procedures are either invasive or have questionable efficacy. Gastric peroral pyloromyotomy (G-POEM) has been proposed as a minimally invasive approach. We performed a pooled analysis to evaluate the efficacy and safety of G-POEM for GP. Methods: Electronic databases (Medline, Scopus, EMBASE) were searched up to January 2019. Studies including patients who underwent G-POEM for GP were eligible. Procedural, clinical, and safety outcomes were assessed by pooling data with a random- or fixed-effect model according to the degree of heterogeneity to obtain a proportion with a 95% confidence interval. Results: Ten studies were eligible for inclusion (292 patients), and 2 of the 10 studies were prospective. Seven studies were performed in the United States, 2 in France, and 1 in China. Endoscopic pyloromyotomy was feasible in all patients. Significant symptomatic improvement was achieved after 83.9% of procedures (mean follow-up, 7.8 ± 5.5 months). When comparing the mean values of pre- and postprocedural scintigraphic evolution, there was a significant decrease of the residual percentage at 2 and 4 hours. The overall adverse events rate was 6.8%. Conclusions: G-POEM appears to be a promising approach for GP in terms of safety and efficacy outcomes in the short term.
AB - Background and Aims: Gastroparesis (GP) is a chronic debilitating condition. Prior pyloric-targeted procedures are either invasive or have questionable efficacy. Gastric peroral pyloromyotomy (G-POEM) has been proposed as a minimally invasive approach. We performed a pooled analysis to evaluate the efficacy and safety of G-POEM for GP. Methods: Electronic databases (Medline, Scopus, EMBASE) were searched up to January 2019. Studies including patients who underwent G-POEM for GP were eligible. Procedural, clinical, and safety outcomes were assessed by pooling data with a random- or fixed-effect model according to the degree of heterogeneity to obtain a proportion with a 95% confidence interval. Results: Ten studies were eligible for inclusion (292 patients), and 2 of the 10 studies were prospective. Seven studies were performed in the United States, 2 in France, and 1 in China. Endoscopic pyloromyotomy was feasible in all patients. Significant symptomatic improvement was achieved after 83.9% of procedures (mean follow-up, 7.8 ± 5.5 months). When comparing the mean values of pre- and postprocedural scintigraphic evolution, there was a significant decrease of the residual percentage at 2 and 4 hours. The overall adverse events rate was 6.8%. Conclusions: G-POEM appears to be a promising approach for GP in terms of safety and efficacy outcomes in the short term.
UR - http://www.scopus.com/inward/record.url?scp=85079165291&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079165291&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2019.11.039
DO - 10.1016/j.gie.2019.11.039
M3 - Review article
C2 - 31809720
AN - SCOPUS:85079165291
SN - 0016-5107
VL - 91
SP - 746-752.e5
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 4
ER -